Page last updated: 2024-08-21

adamantane and Focal Segmental Glomerulosclerosis

adamantane has been researched along with Focal Segmental Glomerulosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hidaka, T; Kubo, A; Nakayama, M; Sasaki, Y; Suzuki, H; Suzuki, Y; Takagi, M	1

Other Studies

1 other study(ies) available for adamantane and Focal Segmental Glomerulosclerosis

Article	Year
Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases. BMC nephrology, 2020, 09-18, Volume: 21, Issue:1 Topics: Adamantane; Antibodies, Antineutrophil Cytoplasmic; Bowman Capsule; Diabetic Nephropathies; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Doxorubicin; Female; Glomerulosclerosis, Focal Segmental; Humans; In Vitro Techniques; Kidney; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Microfilament Proteins; Nephritis; Podocytes; rhoA GTP-Binding Protein	2020

Article

Year

Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.

BMC nephrology, 2020, 09-18, Volume: 21, Issue:1

Topics: Adamantane; Antibodies, Antineutrophil Cytoplasmic; Bowman Capsule; Diabetic Nephropathies; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Doxorubicin; Female; Glomerulosclerosis, Focal Segmental; Humans; In Vitro Techniques; Kidney; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Microfilament Proteins; Nephritis; Podocytes; rhoA GTP-Binding Protein

2020